Mouse
Showing 305–320 of 1434 results
-
-150x150.jpg)
Catenin, beta (CTNNB1) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
Creatine Kinase-BB (CK-BB) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
GPN1 / XAB1 (DNA Repair & Protein Synthesis) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
Chromogranin A / CHGA (Neuroendocrine Marker) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
Chromogranin A / CHGA (Neuroendocrine Marker) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
CDX2 / Caudal Type Homeobox 2 (GI Epithelial Marker) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 228.00 – $ 488.00 -
Mesothelin (Mesothelial Marker) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 199.00 – $ 429.00 -
-150x150.jpg)
OLIG2 (Marker of Glial Brain Tumors) Ultraspecific Antibody
Tested against >20,000 Human Proteins
$ 199.00 – $ 429.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with CPS1 / Carbamoyl-Phosphate Synthetase MS-QAVA™ monoclonal antibody [Clone: CPS1/1022] (solid-line), reveals that less than 0.5% of signal is attributable to non-specific binding of anti-CPS1 / Carbamoyl-Phosphate Synthetase [Clone CPS1/1022] to targets other than CPS1 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-1373-MSM1-P1-anti-CPS1-Carbamoyl-Phosphate-Synthetase-antibody-150x150.png)
Anti-CPS1 / Carbamoyl-Phosphate Synthetase Antibody Clone CPS1/1022
$ 488.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: BP53-12 + DO-7] (solid-line), reveals that less than 10.8% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone BP53-12 + DO-7] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-7157-MSM3-P1-anti-p53-Tumor-Suppressor-Protein-antibody-150x150.png)
Anti-p53 Tumor Suppressor Protein Antibody Clone BP53-12 + DO-7
$ 429.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: BP53-12] (solid-line), reveals that less than 12.9% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone BP53-12] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-7157-MSM1-P1-anti-p53-Tumor-Suppressor-Protein-antibody-150x150.png)
Anti-p53 Tumor Suppressor Protein Antibody Clone BP53-12
$ 429.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with Alkaline Phosphatase / PLAP MS-QAVA™ monoclonal antibody [Clone: ALPP/870] (solid-line), reveals that less than 4.4% of signal is attributable to non-specific binding of anti-Alkaline Phosphatase / PLAP [Clone ALPP/870] to targets other than ALPP protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-250-MSM1-P1-anti-Alkaline-Phosphatase-PLAP-antibody-150x150.png)
Anti-Alkaline Phosphatase / PLAP Antibody Clone ALPP/870
$ 429.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with CD44 / HCAM MS-QAVA™ monoclonal antibody [Clone: HCAM/918] (solid-line), reveals that less than 12.6% of signal is attributable to non-specific binding of anti-CD44 / HCAM Std. Anti-Human, Primate [Clone HCAM/918] to targets other than CD44 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-960-MSM2-P1-anti-CD44-HCAM-antibody-150x150.png)
Anti-CD44 / HCAM Antibody Clone HCAM/918
$ 429.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with Alkaline Phosphatase / PLAP MS-QAVA™ monoclonal antibody [Clone: PL8-F6] (solid-line), reveals that less than 4.2% of signal is attributable to non-specific binding of anti-Alkaline Phosphatase / PLAP [Clone PL8-F6] to targets other than ALPP protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-250-MSM5-P1-anti-Alkaline-Phosphatase-PLAP-antibody-150x150.png)
Anti-Alkaline Phosphatase / PLAP Antibody Clone PL8-F6
$ 429.00 -
![Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: DO-7] (solid-line), reveals that less than 12.1% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone DO-7] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-7157-MSM2-P1-anti-p53-Tumor-Suppressor-Protein-antibody-150x150.png)
Anti-p53 Tumor Suppressor Protein Antibody Clone DO-7
$ 429.00
